Prostate cancer trials in Germany

In Germany 95 Also abroad 1481

95 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer
Where
Heidelberg, Munich
Age
18 years and over
People
75 worldwide
Run by
University of Zurich
See details and how to joinNCT06834152
Phase 1/2Taking people
A Phase I/II Study of Neoadjuvant, Intra-arterial Administration of [177Lu]Lu-PSMA-617 in Subjects with High-risk, Localised or Locally Advanced Prostate Cancer who are Candidates for Radical Prostatectomy (LUPUS)
Where
Essen
Age
18 years and over
People
22
Run by
Universitaetsklinikum Essen AöR
See details and how to join2022-500838-28-00 · EU 2022-500838-28-00
No phaseTaking people
Total en Bloc Urethra Preservation at Robot-assisted Prostatectomy IDEAL Stage 2a
Where
Düsseldorf, Siegen
Age
18 years and over
People
60
Run by
Sami-Ramzi Leyh-Bannurah
See details and how to joinNCT07678489
Phase 2Taking people
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Where
Velbert
Age
18 years and over
People
37 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT04641247 · EU 2023-506618-29-00
Phase 1/2Taking people
A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC
Where
Frankfurt am Main
Age
18 years and over
People
12
Run by
CuraCell TX AB
See details and how to joinNCT07255664 · EU 2025-521227-70-00
Phase 3Taking people
Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.
Where
Bonn, Goettingen, Halle, Recklinghausen, Rostock
Age
18 years and over
People
320 worldwide
Run by
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
See details and how to joinNCT07333066 · EU 2025-524408-30-01
No phaseTaking people
Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer
Where
Jena
Age
18 years to 120 years
People
150
Run by
Jena University Hospital
See details and how to joinNCT06355050
Phase 2Not yet taking people in Germany
Phase 2 trial of ARPI to AR-degrader (BMS-986365) switch for suboptimal PSA-response in mCSPC (eARly-SWITCH).
Where
Duisburg, Düsseldorf, Essen, Frankfurt Am Main, Freiburg im Breisgau, Hamburg, Heidelberg, Herne, Jena, München, Nürnberg, Rostock, Tübingen, Ulm, Wuppertal
Age
18 years and over
People
42
Run by
UroTrials GmbH
See details and how to join2025-523672-23-00 · EU 2025-523672-23-00
Phase 4Taking people
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Where
Cologne, Essen, Munich, Rostock
Age
18 years to 100 years
People
700 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05803941 · EU 2023-503208-94-00
Phase 2Taking people
Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer
Where
Chemnitz, Düsseldorf, Hamburg, Munich
Age
18 years and over
People
168 worldwide
Run by
Curasight
See details and how to joinNCT06474806 · EU 2023-507111-35-00
No phaseTaking people
EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING RARP FOR THE TREATMENT OF PROSTATE CANCER
Where
Gronau, Hamburg, Leipzig
Age
45 years to 68 years
People
362
Run by
St. Antonius Hospital Gronau
See details and how to joinNCT06822036
No phaseTaking people
How Darolutamide Plus Hormone Therapy Works for Men With Advanced Prostate Cancer in Everyday Medical Practice in Germany
Where
Locations
Age
18 years and over
People
500
Run by
Bayer
See details and how to joinNCT07395804
Phase 1/2Taking people
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Where
Aachen, Augsburg, Essen, Marburg, Munich, Regensburg
Age
18 years and over
People
82 worldwide
Run by
Blue Earth Therapeutics Ltd
See details and how to joinNCT05413850 · EU 2024-511537-35-00
Phase 1/2Taking people
Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System
Where
Cologne, Rostock
Age
18 years and over
People
43 worldwide
Run by
SpectraCure AB
See details and how to joinNCT06807359
No phaseTaking people
Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III)
Where
Erfurt, Frankfurt am Main, Kiel, Munich
Age
18 years and over
People
175
Run by
University Hospital Schleswig-Holstein
See details and how to joinNCT06914544
Phase 3Taking people
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
Where
Essen, Hamburg, Münster
Age
18 years and over
People
300 worldwide
Run by
UNICANCER
See details and how to joinNCT04916613 · EU 2022-502425-18-00
Phase 1Enrolling by invitation
Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
Where
Berlin, Dresden, Marburg, Munich, Ulm
Age
18 years and over
People
178
Run by
AvenCell Therapeutics, Inc.
See details and how to joinNCT07474051 · EU 2025-521717-67-00
No phaseTaking people
PROCARE - PROstate Cancer Real World Evidence Registry
Where
Aachen, Augsburg, Bayenthal, Bayreuth, Bergisch Gladbach, Berlin, Bonn, Braunschweig, Dessau, Duisburg, Düsseldorf, Erlangen, Essen, Frankfurt am Main, Freiburg im Breisgau, Giessen, Halle, Hamburg, Heidelberg, Herne, Herzberg am Harz, Hildesheim, Jena, Karlsruhe, Kempten (Allgäu), Leipzig, Lübeck, Magdeburg, Mannheim, Marburg, Neunkirchen, Neustadt am Rübenberge, Nuremberg, Nürtingen, Paderborn, Regensburg, Rostock, Trier, Tübingen, Ulm, Wetzlar, Wilhelmshaven, Wuppertal, Würselen, Würzburg
Age
18 years and over
People
5,000
Run by
UroTrials Company (GmbH)
See details and how to joinNCT06835218
No phaseTaking people
Prostate Cancer Patients Treated With Alternative Radiation Oncology Strategies
Where
Heidelberg
Age
18 years and over
People
897
Run by
University Hospital Heidelberg
See details and how to joinNCT04083937
No phaseTaking people
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Where
Tübingen
Age
18 years and over
People
8,000 worldwide
Run by
UMC Utrecht
See details and how to joinNCT04075305
Phase 4Taking people
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Where
Berlin, Tübingen
Age
18 years to 64 years
People
2,076 worldwide
Run by
Guerbet
See details and how to joinNCT04373564
No phaseTaking people
Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s)
Where
Hamburg
Age
18 years to 75 years
People
397
Run by
Martini-Klinik am UKE GmbH
See details and how to joinNCT04271579
No phaseTaking people
Navigation, Outcomes and Quality-of-life in Prostate Cancer Patients Undergoing PSMA-targeted Surgery
Where
Hamburg
Age
18 years to 78 years
People
102
Run by
Martini-Klinik am UKE GmbH
See details and how to joinNCT07129551
Phase 1/2Not yet taking people in Germany
Open-label clinical phase 1/2 study to assess the safety and efficacy of the SpectraCure P18 System and verteporfin for injection for the treatment of primary localized prostate cancer
Where
Köln, Rostock
Age
18 years and over
People
20
Run by
SpectraCure AB (publ)
See details and how to join2024-519658-35-00 · EU 2024-519658-35-00
No phaseTaking people
Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
Where
Augsburg, Erlangen, Munich
Age
18 years and over
People
200
Run by
University of Erlangen-Nürnberg Medical School
See details and how to joinNCT07131956